Literature DB >> 17276298

Regarding the virtues and limitations of combining myocardial perfusion SPECT data acquired by diverse methods.

Kenneth J Nichols.   

Abstract

Mesh：

Year:  2007        PMID： 17276298     DOI： 10.1016/j.nuclcard.2006.11.008

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  12 in total

1.  Automated quantification of myocardial perfusion SPECT using simplified normal limits.

Authors:  Piotr J Slomka; Hidetaka Nishina; Daniel S Berman; Cigdem Akincioglu; Aiden Abidov; John D Friedman; Sean W Hayes; Guido Germano
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

2.  Combined supine and prone quantitative myocardial perfusion SPECT: method development and clinical validation in patients with no known coronary artery disease.

Authors:  Hidetaka Nishina; Piotr J Slomka; Aiden Abidov; Shunichi Yoda; Cigdem Akincioglu; Xingping Kang; Ishac Cohen; Sean W Hayes; John D Friedman; Guido Germano; Daniel S Berman
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

3.  Combined quantitative supine-prone myocardial perfusion SPECT improves detection of coronary artery disease and normalcy rates in women.

Authors:  Piotr J Slomka; Hidetaka Nishina; Aiden Abidov; Sean W Hayes; John D Friedman; Daniel S Berman; Guido Germano
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

4.  Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation.

Authors:  Yasmin Masood; Yi-Hwa Liu; Gordon Depuey; Raymond Taillefer; Luis I Araujo; Steven Allen; Dominique Delbeke; Frank Anstett; Aharon Peretz; Mary-Jo Zito; Vera Tsatkin; Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

5.  Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability.

Authors:  H Kiat; D S Berman; J Maddahi; L De Yang; K Van Train; A Rozanski; J Friedman
Journal:  J Am Coll Cardiol       Date:  1988-12       Impact factor: 24.094

6.  Results of adenosine single photon emission computed tomography thallium-201 imaging in hemodynamic nonresponders.

Authors:  S V Aksut; S Pancholy; D Cassel; V Cave; J Heo; A S Iskandrian
Journal:  Am Heart J       Date:  1995-07       Impact factor: 4.749

7.  Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.

Authors:  Z X He; A S Iskandrian; N C Gupta; M S Verani
Journal:  J Nucl Med       Date:  1997-01       Impact factor: 10.057

8.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.

Authors:  D S Berman; H Kiat; J D Friedman; F P Wang; K van Train; L Matzer; J Maddahi; G Germano
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

9.  Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact.

Authors:  E G DePuey; A Rozanski
Journal:  J Nucl Med       Date:  1995-06       Impact factor: 10.057

Review 10.  Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging.

Authors:  S Iskander; A E Iskandrian
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.